STERIALS

A clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the central nervous system, rare diseases, immunology, and infectious diseases. The company is conducting clinical trials for drugs to treat fibromyalgia, acute stress disorder, long COVID, cocaine addiction, organ transplant rejection prevention, and autoimmune diseases, as well as developing drugs and vaccines for infectious and rare diseases. Nevada-based